Clinical Scorecard: Effects of Bariatric and Metabolic Surgery on Sarcopenia-Related Factors Based on EWGSOP2 Consensus Guidelines in Individuals with Obesity

At a Glance

Key Highlights

• Bariatric surgery is the most effective treatment for sustainable weight loss but may increase risk of sarcopenia due to muscle mass loss and nutrient deficiencies.
• Sarcopenia diagnosis is best guided by EWGSOP2 criteria emphasizing muscle strength, muscle quantity/quality, and physical performance.
• There is no universal consensus on sarcopenic obesity definitions; EASO/ESPEN recommend considering BMI/waist circumference, low muscle mass, and low muscle function.

Guideline-Based Recommendations

Diagnosis

• Use EWGSOP2 consensus criteria focusing on muscle strength as primary parameter, followed by muscle quantity/quality and physical performance.
• Consider sarcopenic obesity diagnosis by assessing elevated BMI or waist circumference combined with low muscle mass and function per EASO/ESPEN guidelines.
• Employ comprehensive evaluation including physical performance, muscle mass, and strength for accurate sarcopenia diagnosis.

Management

• Monitor and address macronutrient (protein) and micronutrient (vitamin D, magnesium) deficiencies post-bariatric surgery to prevent muscle loss.
• Implement multidisciplinary care to mitigate risk of sarcopenia and associated complications after bariatric surgery.

Monitoring & Follow-up

• Longitudinal assessment of body composition, muscle strength, and physical performance before and after bariatric surgery.
• Regular screening for sarcopenia-related parameters especially within the first months post-surgery when muscle loss risk is highest.

Risks

• Increased risk of sarcopenia or worsening sarcopenic obesity due to accelerated muscle mass and function loss after bariatric surgery.
• Potential development or aggravation of osteoporosis, anemia, and physical disability linked to nutrient deficiencies and muscle loss.

Patient & Prescribing Data

Individuals with obesity undergoing bariatric and metabolic surgery

Bariatric surgery leads to significant fat and muscle mass loss; careful nutritional and functional monitoring is essential to prevent sarcopenia and related adverse outcomes.

Clinical Best Practices

• Adopt EWGSOP2 criteria for sarcopenia diagnosis emphasizing muscle strength and physical performance alongside muscle mass.
• Ensure comprehensive pre- and post-operative evaluation of muscle mass, strength, and physical function in bariatric surgery patients.
• Address nutritional deficiencies proactively to reduce risk of sarcopenia and associated complications.
• Use multidisciplinary approaches integrating nutrition, physical therapy, and medical management for optimal patient outcomes.

References

• EWGSOP2 Sarcopenia Consensus
• EASO/ESPEN Sarcopenic Obesity Recommendations
• ICD-10 Code for Sarcopenia